Your JM Support Community

Cure JM is powered by a community of families who have successfully navigated the JM journey and are here to help you do the same.

Get connected with a network of support, encouragement, and resources.

Two happy children: one with "Hope" chalkboard sign and the other holding a red balloon.

Cure JM is the global leader in juvenile myositis (JM) research. We are paving the way to better treatments for JM while improving the lives of families affected by the disease.

About
Juvenile Myositis

Juvenile myositis involves a run-away immune response where the body’s immune system attacks its own cells and tissues. With proper treatment and care, children can go on to live their best lives.

Was your child recently diagnosed with juvenile myositis?

We are honored to share our new short film, “Our Mission, Our Impact,” highlighting the key aspects of our mission, working together to make life-changing impacts for the patients and families we serve. Please join us in celebrating the impacts of this progress by making a gift and sharing this video.

Resources

Cure JM is a family of families. We have many resources to help the whole family with the JM journey.
Getting the Diagnosis. Megan Curran, MD

Getting the Diagnosis

It often takes a bit of time for children with juvenile myositis (JM) to get a proper diagnosis. This is due to the fact that

DIY Fundraising

Fundraising doesn’t have to be a daunting task…We’d like to invite our families to join us in putting the “Fun” in fundraising.

Get Involved

Discover the many ways you can support and connect with Cure JM.

Play Video

We invite you to get involved with Cure JM. We hope you’ll join us in helping make our mission a success. 

Thanks to your Giving Tuesday support, we are closer to funding more life-changing JM research, best-practice care, and empowering support programs than ever in 2025.
 
We are on our way to reaching our $1 million holiday stretch goal. To help us cross the finish line, our Co-Founders, Tom and Shari Hume, have stepped up with a Founders’ “Over the Top” match.
 
Every gift made between now and midnight of December 31st will be matched dollar-for-dollar up to $25,000, doubling your life-changing impact. Thank you for being a Hope Hero.

Finding a Cure and Better Treatments for Juvenile Myositis

Cure JM is accelerating juvenile myositis research at an unprecedented pace. We are pursuing promising new treatments, funding clinical trials, and improving care for patients.

Accelerate
Research
Pursue Promising
New Treatments
Fund Clinical
Trials
Expand Our Clinical
Care Network

Current Research Updates

With your financial support, Cure JM is proud to have funded Fionnuala McMorrow, a Postgraduate Research Student in the Department of Life Sciences at the University of Bath, to embark on a critical research project. Fionnuala’s team analyzed blood samples from the UK to investigate two specific biomarkers (anti-CCAR1 and anti-Sp4) recently identified in U.S. patients with JDM and related conditions.

Read More

Last year, Cure JM and a team of collaborative researchers received a prestigious $2 million grant from the Chan Zuckerberg Initiative to advance our understanding of juvenile myositis (JM). The goal? To discover new markers in the blood that could lead to more precise, personalized care for children with JM. We are excited to share some of the early results from this research.

Read More

The generous support of our community has been instrumental in funding groundbreaking research this year, led by Dr. Christian Lood at the University of Washington and Cure JM’s Center of Excellence at Seattle Children’s Hospital. Dr. Lood’s team has identified calcified mitochondria in the muscle tissue of JDM patients with calcinosis – a finding that sheds new light on understanding JDM.

Read More

Cabaletta Bio Presents Promising Early Data for CAR-T in Myositis

Exciting news from the European Congress of Rheumatology (EULAR) 2024 last month in Vienna, Austria! Cure JM partner Cabaletta Bio, presented encouraging results from their CAR-T cell therapy, CABA-201, in treating myositis.

Read More

The Chan Zuckerberg Initiative has awarded Cure JM and a consortium of Cure JM-funded researchers a coveted $2 million rare disease research grant to identify new biomarkers in JM and improve precise, personalized care through the identification of cell-to-cell interactions that drive inflammation in juvenile myositis.

Read More

A clinical trial treating patients with juvenile myositis with the drug abatacept resulted in lower disease activity and clinically significant responses in most patients.

Read More

Photo of a young couple

“Cure JM has provided us so much support and connected us to so many families that were experiencing or had experienced the exact same thing. That sense of community helped us get through the ups and downs.”

Leah, Olivia's Mom

Join Cure JM

Membership is free and we’ll connect you with a network of support, encouragement, and resources.

Cure JM supports families, patients, and the juvenile myositis research community.

Interested in DIY fundraising but need help?

We’re here to help!

To have your fundraiser matched, add “DIY Match” in the memo of your online gift or check.